--- title: "Bio Techne (TECH) Fell on Negative Funding Environment" type: "News" locale: "en" url: "https://longbridge.com/en/news/239151699.md" description: "Bio-Techne Corporation (NASDAQ:TECH) has faced significant challenges due to a negative funding environment for biopharmaceuticals and biotech research, as highlighted in Mairs & Power's Q1 2025 investor letter. The company's stock fell 11.74% over the past month and 38.07% over the last year, closing at $47.72 per share. Despite a 9% year-over-year revenue increase to $297 million in Q2 2025, the fund has shifted focus towards AI stocks, believing they offer greater potential for higher returns in a shorter timeframe." datetime: "2025-05-07T13:56:18.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/239151699.md) - [en](https://longbridge.com/en/news/239151699.md) - [zh-HK](https://longbridge.com/zh-HK/news/239151699.md) --- > Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/239151699.md) | [繁體中文](https://longbridge.com/zh-HK/news/239151699.md) # Bio Techne (TECH) Fell on Negative Funding Environment Mairs & Power, an investment advisor, released the “Mairs & Power Balanced Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here. The stock market reached a record high in February. However, tariff uncertainty in March led to a fall in equities, while fixed income benefited from perceived safety. The fund ended the quarter up 0.04%. The fund outperformed the benchmark composite indexes (60% S&P 500 Total Return Index and 40% Bloomberg U.S. Government/Credit Bond Index), down 1.48%, and the Morningstar Moderate Allocation peer group, which fell 0.34%. In addition, please check the fund’s top five holdings to know its best picks in 2025. In its first-quarter 2025 investor letter, Mairs & Power Balanced Fund highlighted stocks such as Bio-Techne Corporation (NASDAQ:TECH). Bio-Techne Corporation (NASDAQ:TECH), with a market capitalization of $7.544 billion, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets. The one-month return of Bio-Techne Corporation (NASDAQ:TECH) was -11.74%, and its shares lost 38.07% of their value over the last 52 weeks. On May 6, 2025, Bio-Techne Corporation (NASDAQ:TECH) stock closed at $47.72 per share. Mairs & Power Balanced Fund stated the following regarding Bio-Techne Corporation (NASDAQ:TECH) in its Q1 2025 investor letter: > **“Bio-Techne Corporation** (NASDAQ:TECH) underperformed due to negativity around the funding environment for biopharmaceuticals and biotech research given recent federal funding cuts and a weak venture capital funding environment. We have taken advantage of the recent weakness to add to our Bio-Techne position.” A scientist working on a complex photonics instruments in a sterile laboratory setting. Bio-Techne Corporation (NASDAQ:TECH) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 24 hedge fund portfolios held Bio-Techne Corporation (NASDAQ:TECH) at the end of the fourth quarter compared to 25 in the third quarter. In the second quarter of fiscal 2025, the company generated $297 million in revenues, up 9% year-over-year on both reported and organic basis. While we acknowledge the potential of Bio-Techne Corporation (NASDAQ:TECH) as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is as promising as NVIDIA but that trades at less than 5 times its earnings, check out our report about the **cheapest AI stock**. In another article, we covered Bio-Techne Corporation (NASDAQ:TECH) and shared Conestoga Capital Advisors’ views on the company. In addition, please check out our hedge fund investor letters Q1 2025 page for more investor letters from hedge funds and other leading investors. READ NEXT: Michael Burry Is Selling These Stocks and A New Dawn Is Coming to US Stocks. Disclosure: None. This article is originally published at Insider Monkey. Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal! **My #1 AI stock pick delivered solid gains since the beginning of 2025** while popular AI stocks like NVDA and AVGO lost around 25%. The numbers speak for themselves: while giants of the AI world bleed, our AI pick delivers, showcasing the power of our research and the immense opportunity waiting to be seized. The whispers are turning into roars. Artificial intelligence isn’t science fiction anymore. It’s the revolution reshaping every industry on the planet. From driverless cars to medical breakthroughs, AI is on the cusp of a global explosion, and savvy investors stand to reap the rewards. Here’s why this is the prime moment to jump on the AI bandwagon: **Exponential Growth on the Horizon:** Forget linear growth – AI is poised for a hockey stick trajectory. Imagine every sector, from healthcare to finance, infused with superhuman intelligence. We’re talking disease prediction, hyper-personalized marketing, and automated logistics that streamline everything. This isn’t a maybe – it’s an inevitability. Early investors will be the ones positioned to ride the wave of this technological tsunami. **Ground Floor Opportunity:** Remember the early days of the internet? Those who saw the potential of tech giants back then are sitting pretty today. AI is at a similar inflection point. We’re not talking about established players – we’re talking about nimble startups with groundbreaking ideas and the potential to become the next Google or Amazon. This is your chance to get in before the rockets take off! **Disruption is the New Name of the Game:** Let’s face it, complacency breeds stagnation. AI is the ultimate disruptor, and it’s shaking the foundations of traditional industries. The companies that embrace AI will thrive, while the dinosaurs clinging to outdated methods will be left in the dust. As an investor, you want to be on the side of the winners, and AI is the winning ticket. **The Talent Pool is Overflowing:** The world’s brightest minds are flocking to AI. From computer scientists to mathematicians, the next generation of innovators is pouring its energy into this field. This influx of talent guarantees a constant stream of groundbreaking ideas and rapid advancements. By investing in AI, you’re essentially backing the future. The future is powered by artificial intelligence, and the time to invest is NOW. Don’t be a spectator in this technological revolution. Dive into the AI gold rush and watch your portfolio soar alongside the brightest minds of our generation. This isn’t just about making money – it’s about being part of the future. So, buckle up and get ready for the ride of your investment life! **Act Now and Unlock a Potential 10,000% Return: This AI Stock is a Diamond in the Rough (But Our Help is Key!)** The AI revolution is upon us, and savvy investors stand to make a fortune. But with so many choices, how do you find the hidden gem – the company poised for explosive growth? That’s where our expertise comes in. We’ve got the answer, but there’s a twist… Imagine an AI company so groundbreaking, so far ahead of the curve, that even if its stock price **quadrupled today**, it would still be considered ridiculously cheap. That’s the potential you’re looking at. This isn’t just about a decent return – we’re talking about a **10,000%** gain over the next decade! Our research team has identified a hidden gem – an AI company with cutting-edge technology, massive potential, and a current stock price that screams opportunity. This company boasts the most advanced technology in the AI sector, putting them leagues ahead of competitors. It’s like having a race car on a go-kart track. They have a strong possibility of cornering entire markets, becoming the undisputed leader in their field. **Here’s the catch (it’s a good one):** To uncover this sleeping giant, you’ll need our exclusive intel. We want to make sure none of our valued readers miss out on this groundbreaking opportunity! That’s why we’re slashing the price of our Premium Readership Newsletter by a whopping **70%**. For a ridiculously low price of just **$29.99**, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single restaurant meal! Here’s why this is a deal you can’t afford to pass up: **• Access to our Detailed Report on this Game-Changing AI Stock:**Our in-depth report dives deep into our #1 AI stock’s groundbreaking technology and massive growth potential. **• 11 New Issues of Our Premium Readership Newsletter:** You will also receive 11 new issues and at least one new stock pick per month from our monthly newsletter’s portfolio over the next 12 months. These stocks are handpicked by our research director, Dr. Inan Dogan. **• One free upcoming issue of our 70+ page Quarterly Newsletter:**A value of $149 **• Bonus Reports:**Premium access to **members-only** fund manager video interviews **• Ad-Free Browsing:**Enjoy a year of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity. **• 30-Day Money-Back Guarantee:** If you’re not absolutely satisfied with our service, we’ll provide a full refund within 30 days, no questions asked. **Space is Limited!** Only **1000 spots** are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment. **Here’s what to do next:** 1\. Head over to our website and subscribe to our Premium Readership Newsletter for just $29.99. 2\. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months. 3\. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee. Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future! Subscribe Now! No worries about auto-renewals! Our 30-Day Money-Back Guarantee applies whether you’re joining us for the first time or renewing your subscription a year later! I work for one of the largest independent financial publishers in the world – representing over 1 million people in 148 countries. We’re independently funding today’s broadcast to address something on the mind of every investor in America right now… **_Should I put my money in Artificial Intelligence?_** Here to answer that for us… and give away his No. 1 free AI recommendation… is 50-year Wall Street titan, Marc Chaikin. Marc’s been a trader, stockbroker, and analyst. He was the head of the options department at a major brokerage firm and is a sought-after expert for _CNBC, Fox Business, Barron’s,_ and _Yahoo! Finance…_ But what Marc’s most known for is his award-winning stock-rating system. Which determines whether a stock could shoot sky-high in the next three to six months… or come crashing down. That’s why Marc’s work appears in every Bloomberg and Reuters terminal on the planet… And is still used by hundreds of banks, hedge funds, and brokerages to track the billions of dollars flowing in and out of stocks each day. He’s used this system to survive nine bear markets… create three new indices for the Nasdaq… and even predict the brutal bear market of 2022, 90 days in advance. **Click to continue reading…** ### Related Stocks - [Bio-Techne Corporation (TECH.US)](https://longbridge.com/en/quote/TECH.US.md) ## Related News & Research - [Bio-Techne’s New COMET Spatial Tools Might Change The Case For Investing In Bio-Techne (TECH)](https://longbridge.com/en/news/281130215.md) - [Notable Tuesday Option Activity: BA, DAL, TECH](https://longbridge.com/en/news/280357079.md) - [Bio‑Techne (TECH) Valuation Check After Earnings Beat And Renewed Institutional Interest](https://longbridge.com/en/news/279308112.md) - [JPMorgan Chase & Co. Sells 633,738 Shares of Bio-Techne Corp $TECH](https://longbridge.com/en/news/280046906.md) - [Aberdeen Group plc Has $499,000 Holdings in Bio-Techne Corp $TECH](https://longbridge.com/en/news/276575933.md)